亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Trends in advanced oral drug delivery system for curcumin: A systematic review

姜黄素 生物利用度 纳米载体 药理学 药物输送 医学 药品 药代动力学 口服 脂质体 纳米技术 材料科学
作者
Suchiwa Pan-On,Piyameth Dilokthornsakul,Waree Tiyaboonchai
出处
期刊:Journal of Controlled Release [Elsevier]
卷期号:348: 335-345 被引量:74
标识
DOI:10.1016/j.jconrel.2022.05.048
摘要

Although curcumin is globally recognized for its health benefits, its clinical application has been restricted by its poor aqueous solubility and stability. To overcome these limitations, nanocarrier-based drug delivery systems (NDS) are one of the most effective approaches being extensively explored over the last few decades to improve curcumin's physicochemical and pharmacological effects. Various NDS could provide productive platforms for addressing the formulation challenge of curcumin, but evidence of such systems has not been summarized. This study aimed to systematically review current evidence of lipid and polymer-based NDS for an oral delivery of curcumin focusing on in vivo models and clinical studies. Among the 48 included studies, 3 studies were randomized controlled clinical trials, while 45 studies were animal models. To date, only five curcumin NDS have been studied in healthy volunteers: γ-cyclodextrin, phytosome, liposome, microemulsion and solid dispersion, while most curcumin NDS have been studied in animal models. Most included studies found that NDS could increase oral bioavailability of curcumin as compared to free curcumin. In conclusion, this systematic review showed evidence of the positive effect of NDS for enhancement of oral bioavailability of curcumin. EXECUTIVE SUMMARY: Curcumin is globally recognized for its health benefits, but its clinical application has been limited by its poor aqueous solubility and stability, which causes poor absorption in the gastrointestinal tract (GI tract) via oral administration. Nanocarrier-based drug delivery systems (NDS) are considered as a productive platform to solve the formulation challenge of curcumin, but evidence of such systems has not been summarized. This study aimed to systematically review current evidence of lipid and polymer-based NDS for an oral delivery of curcumin focusing on in vivo models and clinical studies. Overall, most studies found that all studied NDS could increase the absorption of curcumin as compared to free curcumin. Curcumin was rapidly absorbed and exhibited a long residence time after oral administration of curcumin NDS. In summary, this systematic review showed positive impacts of NDS for enhancement of oral absorption of curcumin.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
楚楚完成签到 ,获得积分10
3秒前
Claudia应助科研通管家采纳,获得150
14秒前
田様应助科研通管家采纳,获得10
15秒前
1分钟前
烟花应助啊哈哈哈哈哈哈采纳,获得10
1分钟前
1分钟前
酷波er应助淡定的过客采纳,获得10
2分钟前
2分钟前
lxlxllx89发布了新的文献求助10
2分钟前
3分钟前
3分钟前
3分钟前
XiaLee完成签到 ,获得积分10
4分钟前
4分钟前
韩祖完成签到 ,获得积分10
4分钟前
4分钟前
4分钟前
小蘑菇应助淡定的过客采纳,获得10
4分钟前
汉堡包应助不安迎夏采纳,获得10
4分钟前
开朗大雁完成签到 ,获得积分10
4分钟前
mayhem完成签到,获得积分10
5分钟前
miki完成签到 ,获得积分10
5分钟前
5分钟前
5分钟前
Ava应助含蓄的秋荷采纳,获得10
5分钟前
5分钟前
6分钟前
Orange应助慈祥的书琴采纳,获得10
6分钟前
6分钟前
Akim应助科研通管家采纳,获得30
6分钟前
深情安青应助科研通管家采纳,获得20
6分钟前
微笑二娘完成签到,获得积分10
7分钟前
7分钟前
微笑二娘发布了新的文献求助10
7分钟前
小丸子完成签到 ,获得积分0
8分钟前
欣欣完成签到 ,获得积分10
8分钟前
英姑应助科研通管家采纳,获得10
8分钟前
8分钟前
牛八先生发布了新的文献求助10
8分钟前
NicotineZen完成签到,获得积分10
8分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Polymorphism and polytypism in crystals 1000
Relation between chemical structure and local anesthetic action: tertiary alkylamine derivatives of diphenylhydantoin 1000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
Checklist of Yunnan Pieridae (Lepidoptera: Papilionoidea) with nomenclature and distributional notes 500
Der Gleislage auf der Spur 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6073841
求助须知:如何正确求助?哪些是违规求助? 7905047
关于积分的说明 16345464
捐赠科研通 5212857
什么是DOI,文献DOI怎么找? 2788016
邀请新用户注册赠送积分活动 1770811
关于科研通互助平台的介绍 1648286